The Canadian Hypertension Education Program (CHEP) is Hypertension Canada's knowledge translation program that targets various healthcare professionals in clinical and community settings, provides annually updated standardized recommendations and clinical practice guidelines to detect, treat and control hypertension. The program includes development of the recommendations, dissemination (both printed and electronic) and evaluation.
The annual, evidence-based recommendations are developed through intense discussion of the clinical implications via a systematic review of the literature followed by critical appraisals of all the new clinical research and taking into account the assessment criteria in the AGREE II instrument. AGREE II stands for The Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument which evaluates the process of practice guideline development and the quality of reporting. Read more about CHEP recommendations overview, process and AGREE II assessment.
The CHEP recommendations for health care providers are then translated and adapted into educational materials for patients and providers. The public recommendations are published in lay and health care professional journals and available for distribution to medical offices, hospitals, clinics, pharmacies, education centres and via a free CHEP mobile application.
The Canadian Hypertension Education Program (CHEP) is operated and funded by Hypertension Canada. The members of the CHEP Committee are unpaid volunteers who contribute their time and expertise to the annual development and dissemination of the CHEP Recommendations. To maintain professional credibility of the content, the process for the development of the recommendations is fully independent and free from external influence. External partners assist with the dissemination of the approved recommendations.
For more information contact Angelique Berg, Chief Executive Officer at email@example.com